Jaiparka tablets 50mg, from Eli Lilly Japan, contains Pirtobrutinib (YJ code: 4291084F1027, standard: 50mg 1 tablet). This highly selective, non-covalent (reversible) Bruton’s tyrosine kinase (BTK) inhibitor targets BTK in the B-cell receptor signaling pathway. It is used in B-cell malignancies like chronic lymphocytic leukemia (CLL) and mantle cell lymphoma, including cases resistant to other BTK inhibitors.
Jaiparka tablets 50mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →